Anest. intenziv. Med. 2013;24(5):350-356

Pre-eclampsia, eclampsia and HELLP syndrome from the anaesthesiologist's perspectiveExpert group of obstetric anaesthesia and analgesia

Nosková Pavlína1,2, Klozová Radka1,3, Bláha Jan1,2,*, Seidlová Dagmar1,4, Štourač Petr1,5
1 Expertní skupina porodnické anestezie a analgezie ČSARIM
2 Klinika anesteziologie, resuscitace a intenzivní medicíny, 1. lékařská fakulta Univerzity Karlovy v Prazea Všeobecná fakultní nemocnice v Praze
3 Klinika anesteziologie a resuscitace, 2. lékařská fakulta Univerzity Karlovy v Praze a Fakultní nemocnicev Motole
4 II. anesteziologicko-resuscitační oddělení Fakultní nemocnice Brno
5 Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta Masarykovy univerzitya Fakultní nemocnice Brno

The text is a part of a series of articles by Expert Group of Obstetric Anesthesia and Analgesia (ESPAA) on current problems in obstetric anaesthesia. This article presents the current view of the treatment and anaesthesia practice and the consequences of pre-eclampsia, eclampsia and HELLP syndrome.

Keywords: caesarean delivery; anaesthesia; pre-eclampsia; severe preeclampsia; eclampsia; HELLP syndrome

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P, Klozová R, Bláha J, Seidlová D, Štourač P. Pre-eclampsia, eclampsia and HELLP syndrome from the anaesthesiologist's perspective. Anest. intenziv. Med. 2013;24(5):350-356.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Al-Safi, Z. et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet. Gynecol., 2011, 118 (5), p. 1102-1107. Go to original source... Go to PubMed...
    2. Yancey, L. M. et al. Postpartum preeclampsia: emergency department presentation and management. J. Emerg. Med., 2011,40 (4), p. 380-384. Go to original source... Go to PubMed...
    3. Helewa, M. E., et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ, 1997, 157 (6), p. 715-725. Go to PubMed...
    4. Wallis, A. B. et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension. United States 1987-2004. Am. J. Hypertens., 2008, 21 (5), p. 521-526. Go to original source... Go to PubMed...
    5. Hutcheon, J. A., Lisonkova, S., Joseph, K. S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol., 2011, 25 (4), p. 391-403. Go to original source... Go to PubMed...
    6. Sibai, B. M. et al. What we have learned about preeclampsia. Semin. Perinatol., 2003, 27 (3), p. 239-246. Go to original source... Go to PubMed...
    7. Duley, L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol., 2009, 33 (3): p. 130-137. Go to original source... Go to PubMed...
    8. Meekins, J. W. et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol, 1994. 101(8): p. 669-74. Go to original source... Go to PubMed...
    9. Maynard, S. E., Karumanchi, S. A. Angiogenic factors and preeclampsia. Semin. Nephrol., 2011, 31 (1), p. 33-46. Go to original source... Go to PubMed...
    10. Duckitt, K., Harrington, D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ, 2005, 330 (7491), p. 565. Go to original source... Go to PubMed...
    11. Štourač, P. Eklampsie. In Pařízek A. Kritické stavy v porodnictví. Praha: Galén 2012, s. 79-81.
    12. Sibai, B. M. Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension, 2008, 52, 5, p. 805-806. Go to original source... Go to PubMed...
    13. Verlohren, S., Stepan, H., Dechend, R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin. Sci. (Lond)., 2012, 122, 2, p. 43-52. Go to original source... Go to PubMed...
    14. Stepan, H. et al. Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience. Z Geburtshilfe Neonatol., 2010, 214, 6, p. 234-248. Go to PubMed...
    15. Podymow, T., August, P. Postpartum course of gestational hypertension and preeclampsia. Hypertens. Pregnancy, 2010, 29, 3, p. 294-300. Go to original source... Go to PubMed...
    16. Wallace, D. H. et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet. Gynecol., 1995, 86, 2, p. 193-199. Go to original source... Go to PubMed...
    17. Bláha, J. et al. Současné postupy v porodnické anestezii I. - peroperační péče u císařského řezu. Anest. intenziv. Med., 2013, 24, 2, p. 91-101.
    18. Yoo, K. Y. et al. A dose-response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int. J. Obstet. Anesth., 2013, 22, 1, p. 10-18. Go to original source... Go to PubMed...
    19. Park, B. Y. et al. Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery. Br. J. Anaesth., 2011, 106, 1, p. 82-87. Go to original source... Go to PubMed...
    20. Yoo, K. Y. et al. Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. Br. J. Anaesth., 2009, 102, 6, p. 812-819. Go to original source... Go to PubMed...
    21. Richa, F. et al. General anesthesia with remifentanil for Cesarean section in a patient with HELLP syndrome. Acta Anaesthesiol. Scand., 2005, 49, 3, p. 418-420. Go to original source... Go to PubMed...
    22. Magee, L. A. et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J. Obstet. Gynaecol. Can., 2008, 30, 3 Suppl, p. S1-48. Go to original source... Go to PubMed...
    23. Altman, D. et al. Do women with pre-eclampsia, and theirbabies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet, 2002, 359, 9321, p. 1877-1890. Go to original source... Go to PubMed...
    24. Lucas, M. J., Leveno, K. J., Cunningham, F. G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med., 1995, 333, 4, p. 201-205. Go to original source... Go to PubMed...
    25. Belfort, M. A. et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N. Engl. J. Med., 2003, 348, 4, p. 304-311. Go to original source... Go to PubMed...
    26. Ehrenberg, H. M., Mercer, B. M. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet. Gynecol., 2006, 108, 4, p. 833-838. Go to original source... Go to PubMed...
    27. Nežádoucí účinky léčiv - paracetamol, přehled účinnnosti a bezpečnosti. Informační zpravodaj Státního ústavu pro kontrolu léčiv, 2012, 5, 10, s. 2-3.
    28. Preeclampsia a management, květen 2013. Dostupné z www: http://www.uptodate.com/contents/preeclampsia-management-and-prognosis?source=search_result&search=preeclampsia+management&selectedTitle=1~150.
    29. Sibai, B. M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol., 2004, 103, 5 Pt, 1, p. 981-991. Go to original source... Go to PubMed...
    30. O'Brien, J. M. et al. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am. J. Obstet. Gynecol., 2002, 186, 3, p. 475-479. Go to original source... Go to PubMed...
    31. Matchaba, P., Moodley, J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst. Rev., 2004, 1, p. CD002076. Go to original source... Go to PubMed...
    32. Martin, J. N., Jr. et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am. J. Obstet. Gynecol., 2003, 189, 3, p. 830-834. Go to original source... Go to PubMed...
    33. Fonseca, J. E. et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am. J. Obstet. Gynecol., 2005, 193, 5, p. 1591-1598. Go to original source... Go to PubMed...
    34. Katz, L. et al. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am. J. Obstet. Gynecol., 2008, 198, 3, p. 283 e1-8. Go to original source... Go to PubMed...
    35. Woudstra, D. M. et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst. Rev., 2010(9): p. CD008148. Go to original source...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.